IP Library Granted Patent US 9,694,302
Granted Patent B2
US 9,694,302 · App. 14/759,764 · Granted Jul 4, 2017

Multi-step separation process

Inventors: Adam Kelliher (Cheshire, GB); Angus Morrison (Cheshire, GB)
Assignee: BASF PHARMA (CALLANISH) LIMITED
B01D15/185A23D9/04B01D15/1892C11B3/10C11C1/08B01D15/426
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,694,302
App. No.
14/759,764
Granted
Jul 4, 2017
Kind
B2
Abstract

The present invention provides a chromatographic separation process for recovering a polyunsaturated fatty acid (PUFA) product from a feed mixture, which comprises: (a) purifying the feed mixture in a first chromatographic separation step using an eluent a mixture of water and a first organic solvent, to obtain an intermediate product; and (b) purifying the intermediate product in a second chromatographic separation step using as eluent a mixture of water and a second organic solvent, to obtain the PUFA product, wherein the second organic solvent is different from the first organic solvent and has a polarity index which differs from the polarity index of the first organic solvent by between 0.1 and 2.0, wherein the PUFA product is other than alpha-linolenic acid (ALA), gamma-linolenic acid (GLA), linoleic acid, an ALA mono- di- or triglyceride, a GLA mono- di- or triglyceride, a linoleic acid mono- di- or triglyceride, an ALA C 1 -C 4 alkyl ester, a GLA C 1 -C 4 alkyl ester or a linoleic acid C 1 -C 4 alkyl ester or a mixture thereof.

Claims (31)

1. A chromatographic separation process for recovering a polyunsaturated fatty acid (PUFA) product from a feed mixture, which comprises:

(a) purifying the feed mixture in a first chromatographic separation step using as eluent a mixture of water and a first organic solvent, to obtain an intermediate product; and

(b) purifying the intermediate product in a second chromatographic separation step using as eluent a mixture of water and a second organic solvent, to obtain the PUFA product,

wherein the second organic solvent is different from the first organic solvent and has a polarity index which differs from the polarity index of the first organic solvent by between 0.1 and 2.0,

wherein the PUFA product is other than alpha-linolenic acid (ALA), gamma-linolenic acid (GLA), linoleic acid, an ALA mono- di- or triglyceride, a GLA mono- di- or triglyceride, a linoleic acid mono, di- or triglyceride, an ALA C1-C4 alkyl ester, a GLA C1-C4 alkyl ester or a linoleic acid C1-C4 alkyl ester or a mixture thereof.

2. The process according to claim 1 , wherein the PUFA product is other than a C18 PUFA, a C18 PUFA mono-, di- or triglyceride, or a C18 PUFA alkyl ester.

3. The process according to claim 1 , wherein the first and second organic solvents both have a polarity index of 3.9 or greater.

4. The process according to claim 1 , wherein the first and second organic solvents are selected from acetonitrile and methanol.

5. The process according to claim 1 , wherein the first organic solvent:water ratio is from 99.9:0.1 to 75:25 parts by volume, or from 99.5:0.5 to 80:20 parts by volume.

6. The process according to claim 1 , wherein the second organic solvent:water ratio is from 99.9:0.1 to 75:25 parts by volume, or from 90:10 to 85:15 parts by volume.

7. The process according to claim 1 , wherein the first organic solvent is methanol and the second organic solvent is acetonitrile, and wherein (a) the methanol:water ratio is from 99.9:0.1 to 85:15 parts by volume, or from 99.9:0.5 to 88:13 parts by volume, and/or (b) the acetonitrile:water ratio is from 90:10 to 80:20 parts by volume or from 88:12 to 85:15 parts by volume.

8. The process according to claim 1 , wherein the first organic solvent is acetonitrile and the second organic solvent is methanol, and wherein (a) the acetonitrile:water ratio is from 99:1 to 75:25 parts by volume or from 96:4 to 80:20 parts by volume, and/or (b) the methanol:water ratio is from 95:5 to 85:15 parts by volume, or from 93:7 to 90:10 parts by volume.

9. The process according to claim 1 , wherein the PUFA product is at least one ω-3 PUFA or at least one ω-3 PUFA derivative, wherein the PUFA derivative is a PUFA in the form of a mono-, di- or tri-glyceride, ester, phospholipid, amide, lactone, or a salt.

10. The process according to claim 1 , wherein the PUFA product is eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), EPA triglyceride, DHA triglyceride, EPA ethyl ester or DHA ethyl ester.

11. The process according to claim 1 , wherein the PUFA product is EPA, or EPA ethyl ester.

12. The process according to claim 1 , wherein the PUFA product is obtained in the second separation step at a purity greater than 95 wt %, or greater than 97 wt %, or greater than 98 wt %, or greater than 98.4 wt %.

13. The process according to claim 1 , wherein the PUFA product contains less than 1 wt %, or less than 0.5 wt %, or less than 0.25 wt %, or less than 0.1 wt %, or less than 0.05 wt %, or less than 0.01 wt %, of alpha-linolenic acid (ALA), mono-, di- and triglycerides of ALA and C1-C4 alkyl esters of ALA.

14. The process according to claim 1 , wherein the PUFA product contains less than 1 wt %, or less than 0.5 wt %, or less than 0.25 wt %, or less than 0.1 wt %, or less than 0.05 wt %, or less than 0.01 wt %, of gamma-linolenic acid (GLA), mono-, di- and triglycerides of GLA and C1-C4 alkyl esters of GLA.

15. The process according to claim 1 , wherein the feed mixture comprises:

(i) the PUFA product, and/or a mono-, di- or triglyceride of the PUFA product and/or a C1-C4 alkyl ester of the PUFA product, and

(ii) ALA and/or a mono-, di- or triglyceride of ALA and/or a C1-C4 alkyl ester of ALA.

16. The process according to claim 1 , wherein the feed mixture comprises:

(i) the PUFA product, and/or a mono-, di- or triglyceride of the PUFA product and/or a C1-C4 alkyl ester of the PUFA product, and

(ii) GLA and/or a mono-, di- or triglyceride of GLA and/or a C1-C4 alkyl ester of GLA.

17. The process according to claim 1 , wherein

the first chromatographic separation step comprises introducing the feed mixture into a stationary bed chromatography apparatus and the second chromatographic separation step comprises introducing the intermediate product into a stationary bed chromatography apparatus;

the first chromatographic separation step comprises introducing the feed mixture into a stationary bed apparatus and the second chromatographic separation step comprises introducing the intermediate product into a simulated or actual moving bed chromatography apparatus;

the first chromatographic separation step comprises introducing the feed mixture into a simulated or actual moving bed chromatography apparatus and the second chromatographic separation step comprises introducing the intermediate product into a stationary bed chromatography apparatus; or

the first chromatographic separation step comprises introducing the feed mixture into a simulated or actual moving bed chromatography apparatus and the second chromatographic separation step comprises introducing the intermediate product into a simulated or actual moving bed chromatography apparatus.

18. The process according to claim 1 , wherein (a) the intermediate product has a lower concentration of impurities selected from ALA, mono, di- and triglycerides of ALA and C1-C4 alkyl esters of ALA than the feed mixture; and/or (b) the PUFA product produced in the second separation step has a lower concentration of said impurities than the intermediate product.

19. The process according to claim 1 , wherein (a) the intermediate product has a lower concentration of impurities selected from GLA, mono, di- and triglycerides of GLA and C1-C4 alkyl esters of GLA than the feed mixture; and/or (b) the PUFA product produced in the second separation step has a lower concentration of said impurities than the intermediate product.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2015
From: KELLIHER, ADAM; MORRISON, ANGUS
To: BASF PHARMA (CALLANISH) LIMITED
Reel/Frame 036182/0921 →
Priority Claims (1)
GB 1300354.6 · Jan 9, 2013 · national
Continuity (2)
Provisional Application 61750389 · Jan 9, 2013
Related Publication 20150344815A1 · Dec 3, 2015